Physicians, case managers, and HCV patients recommend a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus infection with DAA therapies
Educating patients on HCV treatment benefits is crucial for improving adherence. Individualized monitoring, streamlined VPN requirements and expanded telemedicine use may reduce treatment burden and enhance long-term success.
Authors
- David Lin
- Hsin-Jung Lin
- Kyung min Kwon
- Chun-Jen Liu
- Linda Chen
Institutions
- Gilead Sciences (United Kingdom) (GB)
- National Taiwan University Hospital (TW)
- Gilead Sciences (United States) (US)
- Gilead Sciences (Australia) (AU)
Publication Details
- Journal
- Journal of the Formosan Medical Association
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.jfma.2026.01.064
- Citations
- 2
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 46.77